PNEUMOCOCCAL DISEASE
Clinical trials for PNEUMOCOCCAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine for infants aims to fight pneumococcal disease
⭐️ VACCINE ⭐️ OngoingThis phase 2 trial is testing a new pneumococcal vaccine (PG4) in about 605 healthy infants to see if it is safe and triggers a strong immune response. Infants will receive four doses starting at 2 months old, and the new vaccine will be compared to existing vaccines like Prevnar…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:24 UTC
-
New vaccine safety check for infants: PREVENAR 20 under Real-World scrutiny
⭐️ VACCINE ⭐️ OngoingThis study monitors the safety of the PREVENAR 20 vaccine in 1,100 infants aged 2 to 6 months in Japan. Infants receive four doses as part of routine care, and researchers track any side effects. The goal is to ensure the vaccine is safe for widespread use.
Matched conditions: PNEUMOCOCCAL DISEASE
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
New 20-Strain pneumonia vaccine trial launches in china
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine that protects against 20 types of pneumococcal bacteria, which can cause pneumonia and other infections. Around 200 healthy Chinese adults, children, and infants will receive the vaccine to see if it is safe and how well it triggers an immune respon…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC